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Abstract
Exposure to airborne particles is associated with increased cardiovascular morbidity and mortality.
During the combustion of chlorine-containing hazardous materials and fuels, chlorinated
hydrocarbons chemisorb to the surface of transition metal-oxide-containing particles, reduce the
metal, and form an organic free radical. These radical-particle systems can survive in the
environment for days and are called environmentally persistent free radicals (EPFRs). This study
determined whether EPFRs could decrease left ventricular function before and after ischemia and
reperfusion (I/R) in vivo. Male Brown Norway rats were dosed (8 mg/kg, i.t.) 24 hr prior to testing
with particles containing the EPFR of 1, 2-dichlorobenzene (DCB230). DCB230 treatment
decreased systolic and diastolic function. DCB230 also produced pulmonary and cardiac
inflammation. After ischemia, systolic, but not diastolic function was significantly decreased in
DCB230-treated rats. Ventricular function was not affected by I/R in control rats. There was
greater oxidative stress in the heart and increased 8-isoprostane (biomarker of oxidative stress) in
the plasma of treated vs control rats after I/R. These data demonstrate for the first time that
DCB230 can produce inflammation and significantly decrease cardiac function at baseline and
after I/R in vivo. Furthermore, these data suggest that EPFRs may be a risk factor for cardiac
toxicity in healthy individuals and individuals with ischemic heart disease. Potential mechanisms
involving cytokines/chemokines and/or oxidative stress are discussed.
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The public health impacts of airborne particles are well documented with studies
consistently demonstrating correlations between environmental exposure and cardiovascular
disease (1–4). In addition to the epidemiological data, animal studies show that fine and
ultrafine particulates produce cardiovascular toxicity. For example, exposure to fine diesel
exhaust particles increases the size and rate of atherosclerotic plaque formation in apoE
knockout mice (5, 6). These lesions are accompanied by increased oxidative stress and
inflammation in the blood vessels. Particles also decrease heart rate variability (7, 8),
produce cardiac arrhythmias (9–11), increase thrombus formation (12) and alter vascular
reactivity (5, 13). In mice, prior exposure to diesel exhaust particles significantly increases
infarct size after coronary artery ligation, as well as increase inflammation and oxidative
stress in the heart (13). While the specific pathways and mechanisms mediating particulate-
associated cardiovascular toxicity are not well defined, systemic inflammation and oxidative
stress are widely believed to play important contributory roles (see (14)). Although
controversial, several studies show that fine and ultrafine particles can transit the lung and
enter the systemic circulation where they may produce inflammation and/or oxidative stress
in a number of tissues and organs (12, 15, 16).
The majority of airborne fine and ultrafine particles (mean diameter of < 2.5 μm and < 0.1
μm, respectively) are generated in combustion processes or result from secondary reactions
involving combustion by-products (17, 18). Our group has shown that during combustion of
chlorine-containing materials (e.g. hazardous waste incineration), chlorinated hydrocarbons
are formed, which chemisorb to the surface of transition metal-oxide-containing particles,
reduce the metal, and form an organic free radical (19–21). Chemisorption, by definition, is
the formation of a chemical bond between the particle and pollutant to form a new particle-
pollutant system, which persists until a subsequent chemical reaction separates them.
Electron transfer from the chemisorbed organic to the surface of the particle reduces the
transition metal and concomitantly forms the organic radical. The association of the free
radical with the surface of the metal-containing particle stabilizes the radical and reduces its
reactivity with atmospheric oxygen (19). This combination of stability and non-reactivity is
referred to as environmental persistence and we refer to this radical-particle system as an
environmentally persistent free radical (EPFR). EPFRs can persist for hours to days in air
and are capable of redox cycling, resulting in the continuous release of reactive oxygen
species. We have recently documented their existence in samples of airborne fine particles
(22).
The ability of EPFRs to undergo prolonged redox cycling, producing large numbers of free
radicals, raises the possibility that EPFRS may confer a level of biological activity/toxicity
that is greater than that of either the particle or the pollutant alone. While studies examining
the biological activity of EFPRs have only just begun, it was recently shown that EPFRs
produce oxidative stress in human lung epithelial cells in vitro (23) and produce pulmonary
inflammation in neonatal rats (24). Given the relationship between particulate exposure and
cardiovascular disease, we hypothesized that inhaled EPFRs decrease left ventricular
function under basal conditions and after cardiac ischemia followed by reperfusion.
To understand the chemistry and biological actions of EPFRs, we generated EPFRs which
mimic those formed during combustion of chlorinated hydrocarbons and chlorine-containing
fuels. These EPFRs are oxygen-centered semiquinone-type radicals similar to those found in
cigarette smoke and airborne environmental samples (21, 22). The EPFRs used in this study
were composed of the EPFR of 1, 2 dichlorobenzene formed by thermal reaction at 230°C
(DCB230) with silica particles (~200 nm dia.) containing 3% CuO. A unique advantage of
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our approach is that we can reproducibly manufacture well-characterized EPFRs with
environmentally-relevant particles of known size, composition, and quantity.
This study was designed to determine whether intratracheal (i.t.) instillation of DCB230
alters baseline cardiac function in vivo and exacerbates left ventricular dysfunction after a
brief period of ischemia followed by reperfusion. We also sought to determine whether
pulmonary and/or cardiac inflammatory infiltration had a role in DCB230-induced
cardiotoxicity in vivo.
Materials and Methods
Synthesis of ultrafine DCB230 particles
The DCB230 used in this study was created using established protocols (21) and consisted
of an ortho-chlorophenoxyl EPFR produced from the thermal reaction of 1, 2-
dichlorobenzene with silica particles containing 3% CuO at 230°C (DCB230). Particle size
was verified by transmission electron microscopy and flow cytometry (23). Electron
paramagnetic resonance was used to confirm the presence of oxygen-centered EPFRs in our
DCB230 samples (21).
In vivo studies
Animals—Male Brown Norway rats (250 to 320 g; Harlan, Indianapolis, IN) were housed
in a temperature- and humidity-controlled room with a 12-hour light/dark cycle. Standard rat
chow and water were available ad libitum. All procedures were performed in accordance
with National Institutes of Health Guidelines for the Care and Use of Experimental Animals
and were approved by the Institutional Animal Care and Use Committee at Louisiana State
University Health Sciences Center.
Instillation of DCB230—DCB230 was suspended in isotonic saline with 0.02% Tween
80 and sonicated for 1 minute. The rats were anesthetized in an induction chamber with
isoflurane (4%) and were intubated with an 18 ga. catheter. DCB230 (8 mg/kg) or vehicle
(isotonic saline with 0.02% Tween 80) was instilled (1 μl/g body weight) down the
intubation tube as a bolus dose 24 hours before conducting experiments. This dose of
DCB230 was chosen because it is within the range of particle doses that have been shown to
produce cardiac toxicity after a single i.t. instillation in rats and mice (13, 25, 26). Although
the intratracheal route of administration is limited because it does not adequately model real
world inhalation exposures, this method is a reliable and reproducible way to acutely
administer known quantities of particles to the lungs. The 24 hour time point was chosen
based on the report by Cozzi and colleagues (13) who showed increased infarct size,
inflammation and oxidative stress 24 hours after particle instillation.
Left ventricular pressure-volume relationships—Left ventricular performance was
assessed in DCB230 (n=6) and vehicle-treated rats (n=6) in vivo using Millar pressure-
volume conductance catheters (SPR-838) (27). Rats were anesthetized with isoflurane (4%),
intubated and ventilated (isoflurane 2% and 100% oxygen 3 l/min). Tidal volume (3–5 ml)
and respiratory rate (60–70 breaths/min) were adjusted to maintain arterial blood pH
between 7.35 – 7.45. Body temperature was maintained at 37±1°C using a heat lamp. A
cannula (micro-renathane, 0.33 in O.D.) was placed into the right jugular vein to administer
drugs. The pressure-volume catheter was introduced into the left carotid artery and was
advanced into the left ventricle. After a 15 minute equilibration period, baseline parameters
of left ventricular function (closed chest) were calculated using a minimum of 3 consecutive
pressure-volume loops (sampling rate 1000 Hz; MPVS-400, Millar Instruments). The chest
was then opened and the heart was exposed using a mid-sternal approach. A second “open
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chest” baseline of left ventricular function was then obtained. The left anterior descending
coronary artery (LAD) was then occluded for 90 seconds by tying a 6-0 suture around the
vessel between the pulmonary artery and the left atrial appendage. The effectiveness of the
occlusion was verified by blanching of the ventricle distal to the ligature. The ligature was
then removed to initiate reperfusion. Ventricular function was monitored by constructing
pressure-volume loops 1, 5, 30 and 60 minutes after the onset of reperfusion.
Measures of heart rate (HR), peak left ventricular end systolic pressure (ESP), left
ventricular end diastolic pressure (EDP), end diastolic volume (EDV) maximal slope of the
systolic pressure increment (dP/dtmax), diastolic decrement (−dP/dtmin), ejection fraction
(EF), stroke volume (SV), cardiac output (CO), Tau (G) (regression of dP/dtmax) and stroke
work (SW) were computed from the pressure-volume loops using the Millar PVAN analysis
system (27). The pressure-volume conductance catheter was calibrated using whole blood
from vehicle and DCB230-treated rats to generate standard curves of relative volume units.
To determine the absolute left ventricular volume, 35 μl of hypertonic saline (15%) was
injected i.v. to measure the parallel conductance of the system, which was then subtracted
from the total volume (27).
Markers of oxidative stress—At the end of each experiment, the heart was removed,
rinsed in PBS and the right ventricle cut away. The middle portion of the left ventricle and
septum were flash frozen in liquid nitrogen and stored at −80°C. Blood samples were also
collected in serum separator tubes and were centrifuged (4000 rpm for 4 minutes at 4°C).
The plasma samples were treated with 10 μM indomethacin to block enzymatic metabolism
of arachidonic acid during the analysis. The serum samples were frozen at −80°C.
Glutathione (GSH) and oxidized glutathione (GSSG) were measured in cardiac samples
using HPLC with electrochemical detection. Samples of frozen left ventricle were
homogenized in 0.4N perchloric acid and 100 μM diethylenetriamine pentaacetic acid. The
samples were then centrifuged and a small volume was injected onto the HPLC. The
chromatography was performed using a Waters 2690 HPLC pump (Milford, MA) interfaced
to a boron doped diamond electrode controlled through an ESA Coularray detector
(Chelmsford, MA). The separation was achieved using a 3 μM, 25 cm × 4.6 mm I.D.
Supercosil LC-8 reversed phase column. The mobile phase consisted of 25 mM sodium
dihydrogen phosphate containing 1.4 mM 1-octanesulfonic acid and 6% acetonitrile (v/v),
pH 2.65, and was run isocratically at 0.6 ml/min. The elution of GSH and GSSG was
detected at 1500 mV, at about 8.9 and 18.6 minutes, respectively.
8-isoprostane is a biomarker of oxidative stress that is produced in vivo by the peroxidation
of arachidoinc acid. 8-isoprostane levels in plasma were measured using established
methods (28). Briefly, 15% potassium hydroxide and a methanolic solution of butylated
hydroxytoluene (an antioxidant) were added to an equal volume of plasma, and the solution
was incubated at 37°C for 30 min. The saponified samples were then acidified to pH 3.0
using HCl, and 2 ml of 100 mmol of formate buffer (pH 3.0) was added. The samples were
centrifuged at 2400 g for 10 minutes and the resulting supernatants were subjected to solid-
phase extraction using pre-conditioned Oasis HLB 1cc extraction cartridges (Waters Corp.,
Milford, MA) (29). The columns were washed first with 5 ml of 10 mmol/l (pH 3.0) formate
buffer, then with 5 ml (15:85 by volume) acetonitrile-water, and the isoprostanes were
eluted with 2 ml (30:65:5 by volume) hexane-ethyl acetate-propane-2-ol. The level of 8-
isoprostanes was then detected using an ELISA kit from Cayman Chemicals.
Measures of Inflammation
Pulmonary cytokine and chemokine levels—A separate group of rats were treated
with either DCB230 (n=5) or vehicle (n=5). Twenty four hours later the rats were
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anesthetized (4% isolflurane) and intubated. Bronchial alveolar levage was then performed
using 5 ml of sterile PBS containing 2% BSA. The bronchial alveolar levage fluid (BALF)
was centrifuged and the supernatants were collected and frozen at −80°C. The BALF was
assayed for monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein
(MIP-1α), GROKC and the cytokines interleukin-1β (IL-1β), interleukin-6 (IL-6),
interleukin-10 (IL-10), interleukin-18 (IL-18), interferon-gamma (IFN-γ), tumor necrosis
factor-alpha (TNF-α), and VEGF (Milliplex Map Kit). Samples from individual rats were
assayed in duplicate for the controls and triplicate for the DCB230-treated rats.
mRNA arrays for cytokines and chemokines in the heart—In separate studies,
groups of rats were treated with DCB230 (n=3) or vehicle (n=3). Twenty four hours later,
the hearts were removed, sectioned and frozen as described above. Total RNA was isolated
from cardiac tissue using Trizol (Invitrogen, Carlsbad, CA) and further purified using
Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA). The integrity of the extracted RNA was
determined using the Affymetrix chip processing system. cDNA was synthesized using the
RT2 Profiler PCR Array protocol (SABiosciences RT2 First Strand Kit) with 1 mg of total
RNA using the BioRad iCycler® 96-well plate format. The inflammatory cytokine array
was PARN-011 and the oxidative stress array was PARN-065. The cycling conditions were
as follows: an initial denaturation at 95°C for 10 minutes, and 40 cycles of 95°C for 15
seconds, and finally 60°C for 1 minute. Data analysis was performed using the
SABioscience’s PCR Array Data Analysis Web Portal at the following address
http://www.SABiosciences.com/pcrarraydataanalysis.php. Data are reported as fold change
from control values.
Histology—To estimate the size of the ischemic region produced by ligation of the LAD, a
modification of the dye exclusion procedure reported by Cozzi and colleagues (13) was
used. A separate group of rats (n= 3) was deeply anesthetized and the heart exposed. After
ligating the LAD, a 27 gauge needle was introduced into the left ventricle through the apex
and a 1% solution of methylene blue dye was infused. The heart was then excised and
weighed. The nonperfused (ie. ischemic) portion of the left ventricle was removed and the
remaining portion of the heart reweighed. The percent of nonperfused left ventricle was then
calculated.
To look for histological evidence of inflammation, groups of rats were treated with DCB230
(n=3) or vehicle (n=2). Twenty four hours later the rats were deeply anesthetized and the
hearts perfused in situ with saline followed by 4% buffered Zn formalin. The hearts were
then imbedded in paraffin, sectioned (5 μm) and placed on glass slides. Alternate sections of
each heart were stained with hematoxylin-eosin (H & E). Three H & E sections from each
heart were examined blind by the same pathologist. Inflammation was diagnosed by the
accumulation of mononuclear and polymorphonuclear inflammatory cells. Because
interstitial cells can be difficult to characterize on H & E stained slides, macrophages were
further identified by immunohistochemisty in alternate sections stained with monoclonal
antibodies for CD68 (Ventana). Positively stained cells were identified by a brown granular
pigmentation of the cytoplasm and counted. Stained macrophages were counted in the left
ventricle and septum of 3 sections from each heart. The average number of macrophages per
section was then calculated for control and treated hearts. Sections of intestine served as
positive controls, while negative controls consisted of cardiac sections incubated without the
primary antibody.
Statistical Analysis—All data are reported as mean ± SEM. Baseline (close chest)
parameters of cardiac function after DCB230 or vehicle instillation were compared using
unpaired Student’s t-tests (Prism-GraphPad). Between group comparisons of cardiac
function in open chest rats before and after ischemia were made using two-way repeated
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measures analysis of variance followed by Bonferroni post hoc tests (Prism-GraphPad).
Changes in 8-isoprostane levels, cytokine levels, GSH, GSSG and GSH/GSSG ratios were
also compared using Student’s t-test. p<0.05 was considered statistically significant.
Results
Ventricular function
To examine the effects of DCB230 on left ventricular function before and after ischemia and
reperfusion, groups of rats were treated with DCB230 or vehicle. Twenty-four hours later
the rats were anesthetized and pressure-volume curves generated with the chest closed to
determine the effects of the DCB230 alone on ventricular function. Pressure-volume curves
were then obtained with the chest open immediately before occluding the LAD and during
reperfusion. Heart rate was not significantly different in closed chest DCB230 and vehicle-
treated rats (fig. 2). With the chest closed, EDV and −dP/dtmin were significantly lower and
Tau (G) significantly increased in DCB230-treated versus vehicle-treated rats (fig. 1). EDP
was not significantly different between the two groups (fig. 1). With respect to systolic
function, ESP, dP/dtmax, SW and CO were also significantly lower in DCB230-treated rats
as compared to those treated with vehicle (fig. 2). In DCB230-treated rats maximum power
(28.6±3 mWatts) was lower than in vehicle-treated rats (43.1±8 mWatts); however, these
differences were not significant. Stroke volume was lower in DCB230-treated rats, but this
reduction was not significantly different from control (fig. 2). Ejection fraction was nearly
identical in the two groups (DCB230, 49±2% vs vehicle, 55±2%).
After opening the chest, there were no significant differences in any of the baseline
parameters of ventricular function between the treatment groups; however, in most cases
ventricular function in the DCB230-treated rats was reduced relative to controls (figs. 3 and
4). With the chest open, baseline heart rate was similar in the DCB230 and vehicle rats and
remained so throughout the 1 hour reperfusion period (fig. 4). Except for EDV, which was
significantly lower in the DCB230-treated rats 30 minutes after reperfusion, EDP, −dP/dtmin
and Tau (G) were not significantly different between the two groups at any of the time
points (fig. 3). With respect to systolic function, ESP was significantly lower in the DCB230
treatment group than in the vehicle group 1, 30 and 60 minutes after initiating reperfusion
(fig. 4). Stroke work and SV were also significantly lower in DCB230-treated rats 30 and 60
minutes after reperfusion (fig. 4). Stoke volume was significantly lower in the DCB230
treatment group 30 minutes after reperfusion. Although CO and dP/dtmax tended to be
reduced in DCB230-treated rats at most time points during reperfusion, these differences
were not significant (fig 4). Ejection Fraction was similar in both groups (data not shown).
Oxidative stress
To determine whether treatment with DCB230 increased the oxidative stress response to
ischemia and reperfusion in the heart, HPLC was used to examine the levels of reduced
glutathione (GSH) and oxidized glutathione (GSSG) in the hearts of the DCB230 and
vehicle-treated rats subjected to ischemia and 1 hour of reperfusion. Hearts from DCB230-
treated rats had significantly less GSH (0.99±0.9 nmol/mg tissue) than did those from
vehicle-treated rats (1.26±0.08 nmol/mg tissue). Although the amount of GSSG in DCB230-
treated rats was higher than in vehicle-treated rats (0.054±0.016 and 0.033±0.002 nmol/mg
tissue, respectively) this difference was not significant. The ratio of GSH/GSSG was
significantly decreased in DCB230-treated compared to vehicle-treated rats (fig. 5A). There
was no difference in the GSH/GSSG ratio in rats treated with DCB230 or vehicle that were
not subjected to ischemia-reperfusion (data not shown). In addition, the level of 8-
isoprostane (a biomarker oxidative stress) was significantly higher in the plasma of
DCB230-treated rats 1 hour after reperfusion relative to vehicle-treated rats (fig. 5B).
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Cytokines in the BALF
To determine whether EPFRs produced pulmonary inflammation in adult rats, groups of rats
were treated with DCB230 or vehicle, and the BALF collected 24 hours later. Compared to
vehicle treatment, the levels of MCP-1, MIP-1α, IL-1β, IL-6, IFN-γ, IL-18, and TNF-α were
significantly increased in BALF of rats treated with DCB230 (table 1). GROKC, IL-10 and
VEGF were not significantly different between the groups 24 hours after treatment (table 1).
Changes in mRNA levels
Changes in the levels of mRNA in the hearts of DCB230-treated and vehicle-treated rats
were determined using mRNA arrays. DCB230 treatment increased (>1.5 fold) the level of
mRNA encoding chemokine ligand 20 (Ccl20), IL-10, IL-1β and platelet factor 4 (Pf4 or
Cxcl4) (table 2). EPFR treatment also increased the mRNA levels of several cytokine and
chemokine receptors, such as chemokine receptor 5 (Cxcr5), IL-6 receptor α (IL-6rα), IL-1
receptor type 2 (IL-1r2) and the IL-8 receptor β (IL-8rβ) (table 2).
Histology
Dye studies showed that the ligation of the LAD prevented perfusion of 46±1% of the
septum and left ventricle. The hearts of rats exposed to DCB230 24 hours prior contained
significantly higher (p<0.001) numbers of macrophages per cardiac section (41±6) than did
control hearts (20±8). These infiltrating macrophages were distributed throughout the left
ventricle and septum (fig. 6).
Discussion
This study showed for the first time, that instillation of a single dose of DCB230 can
decrease left ventricular volume and decreases diastolic function in vivo, as indicated by
significant decreases in −dP/dtmin and Tau (G). In addition, these studies show for the first
time that exposure to DCB230 also reduced systolic function in vivo, as evidenced by
significant reductions in ESP, dP/dtmax, SW and CO. The decreases in left ventricular
function observed in vivo are consistent with those produced by particulates in isolated heart
preparations.
Badgate and colleagues (25) instilled ultrafine diesel exhaust particles into the lungs of
spontaneously hypertensive rats (SHR) or normotensive control rats 4 hours before
measuring left ventricular function using the isolated heart preparation. Exposure to diesel
particles significantly reduced contractile function in the isolated hearts when compared to
the control. In separate studies, left ventricular systolic function was also decreased when
isolated hearts from normotensive rats and SHR were directly perfused with diesel exhaust
particles, leading to the conclusion that ultrafine particulates can directly reduce cardiac
function (30, 31). Exposure to diesel exhaust particles also reduced fractional shortening in
normal rats before and after isoproterenol –induced ventricular damage (32). In addition,
inhalation of carbon black particles also reduced left ventricular function in senescent and
middle aged mice (33). In humans, epidemiological and experimental data also show that
exposure to airborne particulates increases the risk of myocardial infarction, atherosclerosis,
arrhythmia and decrease heart rate variability (an index of autonomic dysfunction) (1, 3, 4,
14).
In most cases, the exact mechanisms responsible for the cardiovascular and cardiac actions
of inhaled particles are largely unknown, but most available evidence indicates that
inflammation and oxidative stress play prominent roles (14, 34). The present studies show
that our combustion generated EPFRs (DCB230) produce pulmonary inflammation in adult
rats that is similar to that elicited by exposure to environmental samples of ultrafine
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particulates (35). EPFRs also produce pulmonary inflammation in neonatal mice (36). The
“spill over” of pro-inflammatory cytokines, chemokines and inflammatory cells from the
lung is believed to produce systemic inflammation. EPFRs also produced cardiac
inflammation in our rats as evidenced by the infiltration of inflammatory cells into the heart
and increases in the levels of mRNA encoding pro-inflammatory cytokines and cytokines
and their receptors. Thus far, it has yet to be determined whether the observed cardiac
inflammation results from the actions of circulating cytokines and chemokines and/or the
localized actions of particles on the heart.
The prior administration of DCB230 also led to significant decreases in left ventricular
function after 90 seconds of ischemia followed by reperfusion. Reperfusion of the ischemic
myocardium is associated with marked increases in oxidative stress and enhanced
inflammation leading to further degradation of ventricular function (37, 38). Most models of
cardiac ischemia-reperfusion use a 20–30 minute period of ischemia (39–41). Because we
were concerned that the large functional deficits normally produced by long periods of
ischemia would overwhelm or obscure the potential effects of the DCB230, we used a 90
second period of ischemia that did not significantly decrease ventricular function in vehicle-
treated rats. Clinically, this model is relevant because vasospastic (Prinzmetal’s) and
classical angina are characterized by relatively brief periods ischemia and reperfusion. Dye
studies showed that ligation of the LAD decreased perfusion to 46% of the heart without
significantly affecting diastolic or systolic function in the vehicle-treated rats. Conversely, in
rats treated twenty four hours prior with DCB230, significant decreases in systolic function
were observed after 30 to 60 minutes of reperfusion, as evidenced by significant decreases in
ESP, SW and SV. Although not significantly different from vehicle-treated rats, CO and dP/
dtmax also trended downward over time in DCB230-treated rats, further suggesting systolic
dysfunction. Surprisingly, diastolic function was not significantly affected by ischemia and
reperfusion.
In this study, the GSH/GSSG ratio and plasma 8-isoprostane level were not changed by the
administration of DCB230 alone. However, during reperfusion the degraded systolic
ventricular function in the DCB230-treated rats was accompanied by increased oxidative
stress in the myocardium (reduced GSH/GSSG ratio) and plasma (increased 8-isoprostane
levels). Oxidative stress and increased inflammation were also reported to underlie the
doubling of infarct size observed in mice treated with environmentally derived particles
twenty four hours prior to coronary artery ligation (13). Exposure to tobacco smoke (another
source of particles) also dose-dependently increases infarct size in rats (42). Isolated rat
hearts, previously treated (4 hours) in vivo with diesel particles, showed greater contractile
deficits after 20 minutes of ischemia and were slower to recover function after ischemia than
were saline treated hearts (25).
Inflammation and oxidative stress could also account for the decreases in ventricular
function we observed twenty four hours after particle administration under both basal
conditions and after mild ischemia-reperfusion. It is unlikely that structural remodeling was
responsible for the decrease in basal EDV observed twenty four hours after the
administration of a single dose of DCB230. It is more likely that the decrease in EDV was
the consequence of increased pulmonary vascular resistance and reduced pulmonary venous
return to the heart secondary to pulmonary inflammation. Exposure to carbon black particles
has been shown to increase right ventricular and pulmonary vascular pressures in 28 month
old mice (33). To confirm the possible link between pulmonary inflammation and increased
pulmonary resistance in our model, it will be necessary to determine whether DCB230
increases right atrial pressure and/or pulmonary arterial pressure. Pro-inflammatory
cytokines from the lung may also decrease basal systolic and diastolic function by direct
actions on the heart, especially given the fact that cytokines released into the pulmonary
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circulation would reach the heart and coronary circulation at concentrations substantially
greater than those found in the systemic circulation. As reviewed by Prabhu (43), the
intravenous or intracoronary administration of pro-inflammatory cytokines such as IL-1β,
TNF-α, IL-2 and IL-6 elicits rapid changes in contractile function that vary (positive or
negative) depending on the physiological state of the animal. The variable initial response is
consistently followed by a prolonged decrease in inotropy that can last for days. The
mechanism(s) mediating the cardiodepression are not known, but likely reflect a complex
interaction between NO, reactive oxygen species and changes in beta adrenergic receptor
function and signaling (43). As described below, cytokines derived from inflammatory cells
and from the myocardium itself may also contribute to the EPFR mediated decrease in
ventricular function.
Although controversial, there is evidence that fine and ultrafine particles transit from the
lung to the systemic circulation, producing oxidative stress and eliciting inflammatory
responses as they transit the body and in their final deposition sites (44). In vitro, various
types of particles release cytokines and elicit oxidative stress responses in a variety of cell
types (45–47). EPFRs produce oxidative stress responses in human lung epithelial cells (23).
Whether our EPFRs or those contained in environmental samples transit from the lung and
produce or enhance localized oxidative damage in vivo remains to be determined.
Lung derived cytokines and chemokines may account for the increased expression of pro-
inflammatory genes, their receptors and the infiltration of inflammatory cells into the hearts
of DCB230-treated rats. While our data do not address the question of whether the particles
themselves, via the initiation of local inflammatory responses, contribute to the pro-
inflammatory state of the myocardium, recent evidence suggests that lung derived cytokines
and particles may work in concert to enhance the immune response in the heart.
Administration of ultrafine carbon particles or environmental samples to cultured cardiac
myocytes or cardiac fibroblasts stimulates cytokine release (47). However, when the
cultured myoctyes or fibroblasts were treated with particles and conditioned media from
lung epithelial cells treated with the same particles, marked increases in IL-6 and IL-1β were
elicited. Cytokine release was further increased when cocultures of myocytes and fibroblasts
were treated with particles and conditioned media. The question of whether a similar
“cooperative” mechanism accounts for the pro-inflammatory state of the heart after DCB230
treatment in vivo is currently being examined by our group. Regardless of the exact
mechanisms, our data and that of others suggest that exposure to particles produces a pro-
inflammatory state in the heart which leaves the heart more vulnerable to ischemic injury.
Potential mechanisms responsible for this vulnerability could include decreased antioxidant
defenses, “primed or enhanced” inflammatory and oxidative stress responses and/or
oxidative damage by the radical containing EPFR themselves. In addition to these
mechanisms, other contributing factors could include changes in autonomic function,
increased potential for thrombus formation and changes in vascular function. Regardless of
the ultimate mechanism(s), the observation that particle exposure can amplify the
pathophysiolgical response of the heart to ischemia-reperfusion suggests that some types of
combustion-generated airborne particles may pose a serious additional risk to individuals
having ischemic heart disease.
These studies show that the instillation of ultrafine DCB230 produce pulmonary and cardiac
inflammation, decrease basal cardiac function in vivo and induce the expression of pro-
inflammatory genes in the heart. In addition, our data show that prior treatment with
DCB230 significantly decreases ventricular function and increases oxidative stress in the
heart after a brief period of myocardial ischemia, followed by reperfusion. Take together,
these data show that EPFRs may affect cardiac function in healthy individuals and pose a
special risk to individuals with ischemic heart disease.
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EPFRs decrease baseline diastolic left ventricular function in closed chest rats. Rats were
treated with DCB230 (8 mg/kg, i.t.) or vehicle 24 hrs prior to the experiment. Left
ventricular function was measured using Millar pressure-volume catheters. Data are mean ±
SEM. Abbreviations: EDV, end diastolic volume; EDP, end diastolic pressure; −dP/dtmin,
diastolic decrease in pressure vs time; Tau (G). ***p<0.001, **p<0.01, and * p<0.05.
Lord et al. Page 13














EPFRs decrease baseline systolic left ventricular function in closed chest rats. Rats were
treated with DCB230 or vehicle as in figure 1. Data are reported as mean ± SEM.
Abbreviations: ESP, end systolic pressure; dP/dtmax, change in pressure vs change in time
during systole; SW, stroke work; SV, stroke volume; CO, cardiac output. ***p<0.001,
**p<0.01, and *p<0.05.
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EPFRs do not alter diastolic function after a brief myocardial ischemia. Rats were treated
with DCB230 (n=6) or vehicle (n=6) 24 hr prior, as described in figure 1. Ventricular
function was measured at baseline (B) before occluding the lower anterior descending
coronary artery for 90s followed by reperfusion (I/R). Ventricular function was also
measured 1, 5, 30 and 60 minutes after starting reperfusion. Data are means ± SEM.
Abbreviations: as in figure 1.
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EPFRs decrease left ventricular systolic function after brief cardiac ischemia and
reperfusion. These are the same rats and experimental set up as described in figure 3. Data
are means ± SEM. Abbreviations: as in figure 2. **p<0.01, and *p<0.05.
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EPFRs increase oxidative stress in heart and plasma after I/R. Rats are the same as reported
in figures 1–4. Levels GSH and GSSG in the heart and 8-iosprostane in plasma were
measured using HPLC with electrochemical detection. Data are means ± SEM. ** p<0.01,
and *p<0.05.
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Section of the left ventricle of a vehicle-treated (A) and a DCB230-treated (B) rat showing
increased macrophage infiltration (darkly stained cells) 24 hours after i.t. instillation of
DCB230.
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Table 1
BALF cytokine levels following DCB230 exposure
Vehicle DCB230
MCP-1 69 ± 29 1369 ± 365**
MIP-1α ND 124 ± 16***
IL-1β 10 ± 2 119 ± 23**
IL-6 ND 2583 ± 362***
IL-10 ND ND
INF-γ 3 ± 2 65 ± 19*
IL-18 111 ± 17 472 ± 23***
GROKC 874 ± 128 1401 ± 661
TNF-α ND 26 ± 6**
VEGF 76 ± 24 88 ± 7






p<0.001. ND = below the level of detection.
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